PRESS RELEASE

CELLECTIS has choosen ACCELERA as the preferred partner to provide the preclinical studies for UCART19
*******
Download  full  announcement

To know more about the agreement
Karolinska Development / Accelera

Click Here
************************

Do you have a Drug Candidate
to move to Clinics?

Accelera helps you
contact  us

Accelera seminar
at Parc Cientific
de Barcelona

Drug Development: Novel Strategic approach to Preclinical Phases

February 18th

Meet Accelera
at SOT
in San Diego

22-26 March, 2015

ACCELERA
PRESENTATION

logo SITOX 2015